Abstract
Abnormalities of blood coagulation are not rarely observed in patients with thyroid dysfunctions and may range from subclinical laboratory abnormalities to clinically significant hemorrhagic or thrombotic complications. In this review, we summarize the current knowledge on thyroid-associated autoimmune coagulation disorders (i.e., autoimmune thrombocytopenic purpura, antiphospholipid syndrome, and autoantibodies against coagulation factor VIII) and discuss their laboratory characteristics, clinical impact, and recent progresses in the understanding of pathogenesis. Finally, we conclude that the prompt recognition of possible concomitant autoimmune coagulation disorders is important for the correct management of these patients.
Similar content being viewed by others
References
Squizzato A, Romualdi E, Büller HR, Gerdes VEA (2007) Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 92:2415–2420. doi:10.1210/jc.2007-0199
Squizzato A, Gerdes VEA, Ageno W, Büller HR (2007) The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2:76–83. doi:10.1007/s11739-007-0026-X
Franchini M (2004) Hemostasis and thyroid diseases revisited. J Endocrinol Invest 27:886–892
Marongiu F, Cauli C, Mariotti S (2004) Thyroid, hemostasis and thrombosis. J Endocrinol Invest 27:1065–1071
Franchini M, Lippi G, Manzato F, Vescovi PP (2009) Thyroid dysfunction and hemostasis: a still unsolved issue. Semin Thromb Hemost (in press)
Erem C, Ersöz H, Karti SS et al (2002) Blood coagulation and fibrinolysis in hyperthyroidism. J Endocrinol Invest 25:345–350
Ford HC, Carter JM (1990) Haemostasis in hypothyroidism. Postgrad Med J 66:280–284. doi:10.1136/pgmj.66.774.280
Erem C, Kavgaci H, Ersöz H et al (2003) Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 57:78–81
Erem C (2006) Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 64:323–329. doi:10.1111/j.1365-2265.2006.02464.x
Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86:732–737. doi:10.1210/jc.86.2.732
Ochs N, Auer R, bauer DC et al (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832–845
Palareti G, Biagi G, Legnani C et al (1989) Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 62:1053–1056
Myrup B, Bregengård C, Faber J (1995) Primary haemostasis and thyroid disease. J Intern Med 238:59–63
Kurata Y, Nishioeda Y, Tsubakio T, Kitani T (1980) Thrombocytopenia in Graves’ disease: effect of T3 on platelet kinetics. Acta Haematol 63:185–190
Panzer S, Haubenstock A, Minar E (1990) Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111Indium labeled platelet kinetics and platelet associated immunoglobulins G and M. J Clin Endocrinol Metab 70:491–496
Marshall JS, Weisberger AS, Levy RP (1967) Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann Intern Med 67:411–414
Adrouny A, Sandler R, Carmel R (1982) Variable presentation of thrombocytopenia in Graves’ disease. Arch Intern Med 142:1460–1464. doi:10.1001/archinte.142.8.1460
Pinals RS, Tomar RH, Haas DC, Farah F (1977) Graves’ disease, myasthenia gravis and purpura. Ann Intern Med 87:250
Yamaguchi K, Ookubo Y, Matsuda H, Suzaki K, Fujushima H, Uzwa H (1987) Idiopathic thrombocytopenic purpura subsequent to Graves’ disease and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 3:233–237. doi:10.1016/S0168-8227(87)80045-1
Lio S, Albin M, Girelli G et al (1993) Abnormal thyroid function test results in patients with Fisher Evans syndrome. J Endocrinol Invest 16:163–167
Ho SL, Shah M, Williams AC (1992) Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 15:966–967
Cordiano I, Betterle C, Spadaccino CA, Soini B, Girolami A, Fabris F (1998) Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol 113:373–378. doi:10.1046/j.1365-2249.1998.00677.x
Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE (1997) Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 157:1033–1036. doi:10.1001/archinte.157.9.1033
Ikeda K, Maruyama Y, Yokoyama M et al (2001) Association of Graves’ disease with Evans’ syndrome in a patient with IgA nephropathy. Intern Med 40:1004–1010. doi:10.2169/internalmedicine.40.1004
Yashiro M, Nagoshi H, Kasuga Y et al (1996) Evans’ syndrome associated with Graves’ disease. Intern Med 35:987–990. doi:10.2169/internalmedicine.35.987
Bizzaro N (1992) Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am J Hematol 39:294–298. doi:10.1002/ajh.2830390411
Crabtree GR, Lee JC, Cornwell GG (1975) Autoimmune thrombocytopenic purpura and Hashimoto’s thyroiditis. Ann Intern Med 83:371–372
Kang MY, Hahm JR, Jung TS, Lee GW, Kim DR, Park MH (2006) A 20-year-old woman with Hashimoto’s thyroiditis and Evans’ syndrome. Yonsei Med J 47:432–436
Kohli RS, Bleibel W, Bleibel H (2007) Concurrent immune thrombocytopenic purpura and Guillain–Barre syndrome in a patient with Hashimoto’s thyroiditis. Am J Hematol 82:307–308. doi:10.1002/ajh.20771
Segal BM, Weintraub MI (1976) Hashimoto’s thyroiditis, myasthenia gravis, idiopathic thrombocytopenic purpura. Ann Intern Med 85:761–763
Hymes K, Blum M, Lackner H, Karpatkin S (1981) Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves’ disease and Hashimoto’s thyroiditis. Ann Intern Med 94:27–30
Sugimoto K, Sasaki M, Isobe Y, Tamayose K, Hieda M, Oshimi K (2005) Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy. Eur J Haematol 74:73–74. doi:10.1111/j.1600-0609.2004.00341.x
Cao Q, Liu X, Liu J (1994) Determination of thyroid hormones in 72 patients with idiopathic thrombocytopenic purpura and its clinical significance. Clin Lab Haematol 16:90–91
Pratt EL, Tarantino MD, Wagner D, Hirsch Pescovitz O, Bowyer S, Shapiro AD (2005) Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura. Am J Hematol 79:175–179. doi:10.1002/ajh.20299
Herman J, Resnitzky P, Fink A (1978) Association between thyrotoxicosis and thrombocytopenia. A case report and review of the literature. Isr J Med Sci 14:469–475
Jacobs P, Majoos F, Perrotta A (1984) Hyperthyroidism and immune thrombocytopenia. Postgrad Med J 60:657–661. doi:10.1136/pgmj.60.708.657
Altintas A, Pasa S, Cil T, Bayan K, Gokalp D, Ayyildiz O (2008) Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets 19:252–257. doi:10.1080/09537100801894651
Bowles KM, Turner GE, Wimperis JZ (2004) Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism. J Clin Pathol 57:995–996. doi:10.1136/jcp.2004.016543
Jenkins RC, Weetman AP (2002) Disease associations with autoimmune thyroid disease. Thyroid 12:977–988. doi:10.1089/105072502320908312
Liebman H (2007) Other immune thrombocytopenias. Semin Hematol 44(suppl 5):S24–S34. doi:10.1053/j.seminhematol.2007.11.004
Franchini M (2006) The antiphospholipid syndrome: an update. Clin Lab (Zaragoza) 52:11–17
Hughes GR, Asherson RA, Khamashta MA (1989) Antiphospholipid syndrome: linking many specialties. Ann Rheum Dis 48:355–356. doi:10.1136/ard.48.5.355
Kandiah DA, Krilis SA (1994) Beta 2-glycoprotein. Lupus 3:207–212. doi:10.1177/096120339400300401
McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120–4124. doi:10.1073/pnas.87.11.4120
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763. doi:10.1056/NEJMra002974
Galli M (2003) Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol Haemost Thromb 33:249–255. doi:10.1159/000083810
Paggi A, Caccavo D, Ferri GM et al (1994) Anticardiolipin antibodies in autoimmune thyroid disease. Clin Endocrinol (Oxf) 140:329–333
Mayaudon H, Crozes P, Riveline JP, Boyer B, Simon P, Bauduceau B (1994) Anticorps antiphospholipides au cours d’une maladie de Basedow. Presse Med 23:1496
Hofbauer LC, Spitzweg C, Heufelder AE (1996) Graves’ disease associated with the primary antiphospholipid syndrome. J Rheumatol 23:1435–1437
Presti C, Hart RG (1989) Thyrotoxicosis, atrial fibrillation and embolism, revisited. Am Heart J 117:976–977. doi:10.1016/0002-8703(89)90642-X
Dagenais P, Urowitz MB, Gladman DD, Norman CS (1992) A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 19:1393–1396
Marongiu F, Conti M, Murtas ML et al (1991) Anticardiolipin antibodies in Grave’s disease: relationship with thrombin activity in vivo. Thromb Res 64:745–749. doi:10.1016/0049-3848(91)90074-7
Takahashi A, Tamura A, Ishikawa O (2002) Antiphospholipid antibody syndrome complicated by Grave’s disease. J Dermatol 29:776–780
Nabriski D, Ellis M, Ness-Abramof R, Shapiro M, Shenkman L (2000) Autoimmune thyroid disease and antiphospholipid antibodies. Am J Hematol 64:73–75. doi:10.1002/(SICI)1096-8652(200005)64:1<73::AID-AJH14>3.0.CO;2-U
Petri M, Karlson EW, Cooper DS, Ladenson PW (1991) Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 18:1529–1531
Hofbauer LC, Heufelder AE (1997) Coagulation disorders in thyroid diseases. Eur J Endocrinol 136:1–7. doi:10.1530/eje.0.1360001
Franchini M, Gandini G, Di Paolantonio T, Mariani G (2005) Acquired hemophilia: a concise review. Am J Hematol 80:55–63. doi:10.1002/ajh.20390
Hay CRM (1998) Acquired haemophilia. Baillieres Clin Haematol 11:287–303. doi:10.1016/S0950-3536(98)80049-8
Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45:200–203
Franchini M, Girelli D, Olivieri O et al (2005) Clinical heterogeneity of acquired hemophilia A: a description of four cases. Haematologica 90:ECR16
Meiklejohn DJ, Watson HG (2001) Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 7:523–525. doi:10.1046/j.1365-2516.2001.00519.x
Sievert R, Goldstein ML, Surks MI (1996) Graves’ disease and autoimmune factor VIII deficiency. Thyroid 6:245–247
Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S (2002) Apathetic Graves’ disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 25:246–249
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Franchini, M., Lippi, G., Manzato, F. et al. Thyroid-associated autoimmune coagulation disorders. J Thromb Thrombolysis 29, 87–91 (2010). https://doi.org/10.1007/s11239-009-0327-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-009-0327-1